Thereafter, we examined whether EWS shRNA plasmid transfection and TFL treatment might work together to reduce viability of human Ewing’s sarcoma SK-N-MC and RD-ES cell lines (Figure 2). The gene discussed is ZC3H12D; the disease is Ewing sarcoma.